WallStreetZenWallStreetZen

NASDAQ: MGX
Metagenomi Therapeutics Inc Stock Ownership - Who owns Metagenomi Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Metagenomi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pamela WapnickChief Financial Officer2026-03-051,581$1.60
$2.53kSell
Matthew WeinTitle General Counsel Compliance Officer and Corporate Secretary2026-03-05482$1.60
$771.20Sell
Jian IrishChief Executive Officer2026-03-051,607$1.60
$2.57kSell
Jian IrishChief Executive Officer2025-12-051,602$1.77
$2.84kSell
Matthew WeinTitle General Counsel Compliance Officer and Corporate Secretary2025-12-05199$1.77
$352.63Sell
Brian C. ThomasDirector2025-12-053,830$1.77
$6.79kSell
Pamela WapnickChief Financial Officer2025-12-051,576$1.77
$2.79kSell
Jian IrishChief Executive Officer2025-12-01211,000$1.60
$337.60kBuy
Pamela WapnickChief Financial Officer2025-12-01120,000$1.60
$192.00kBuy
Matthew WeinTitle General Counsel Compliance Officer and Corporate Secretary2025-12-0196,000$1.60
$153.60kBuy

1 of 2

MGX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGX insiders and whales buy or sell their stock.

MGX Shareholders

What type of owners hold Metagenomi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bayer Healthcare LLC10.77%4,050,997$5.47MInsider
Sebastian Bernales8.16%3,068,786$4.14MInsider
Brian C. Thomas6.67%2,510,960$3.39MInsider
Holdings A. Novo4.62%1,739,175$2.35MInsider
Vanguard Group Inc3.38%1,270,246$1.71MInstitution
Jian Irish1.79%672,483$907.85kInsider
Renaissance Technologies LLC1.67%628,400$848.34kInstitution
Catalio Capital Management LP1.41%528,993$714.14kInstitution
Peapod Lane Capital LLC1.32%497,653$671.83kInstitution
Two Sigma Investments LP1.17%441,388$595.87kInstitution

1 of 3

MGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGX17.98%34.09%Net BuyingNet Selling
MREO7.77%4.17%
EDSA24.56%75.44%Net BuyingNet Buying
NBY2.45%97.55%Net Buying
ALGS6.85%93.15%
View Top Biotech Stocks

Metagenomi Therapeutics Stock Ownership FAQ

Who owns Metagenomi Therapeutics?

Metagenomi Therapeutics (NASDAQ: MGX) is owned by 17.98% institutional shareholders, 34.09% Metagenomi Therapeutics insiders, and 47.93% retail investors. Bayer Healthcare LLC is the largest individual Metagenomi Therapeutics shareholder, owning 4.05M shares representing 10.77% of the company. Bayer Healthcare LLC's Metagenomi Therapeutics shares are currently valued at $5.47M.

If you're new to stock investing, here's how to buy Metagenomi Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.